PUBLICATIONS
Browse by category
Articles
Books/Chapters
Patents
Reviews
JOURNAL ARTICLES
Options to Improve the Action of PROTACs in Cancer: Development of Controlled Delivery Nanoparticles
Juan A, Del Mar Noblejas-López M, Arenas-Moreira M, Alonso-Moreno C, Ocaña A. Front Cell Dev Biol. 2022 Feb 3;9:805336. PMID: 35186955; PMCID: PMC8851355 doi: 10.3389/fcell.2021.805336.
Clinical considerations for the design of PROTACs in cancer
Nieto-Jiménez C, Morafraile EC, Alonso-Moreno C, Ocaña A. Mol Cancer. 2022 Mar 7;21(1):67. PMID: 35249548; PMCID: PMC8900451. doi: 10.1186/s12943-022-01535-7
A bis(pyrazolyl)methane derivative against clinical Staphylococcus aureus strains isolated from otitis externa
Ocaña AV, Aguilera-Correa JJ, Domínguez-Jurado E, Pérez-Martínez FC, Pérez-Tanoira R, López-Carretero Y, Masiá-Mondejar J, Castro-Osma JA, Esteban J, Alonso-Moreno C, Molina-Alarcón M, Seguí P. Laryngoscope Investig Otolaryngol. 2022 Jan 18;7(1):283-290. PMID:...
Characterization of Tuna Gelatin-Based Hydrogels as a Matrix for Drug Delivery
Hermida-Merino C, Cabaleiro D, Lugo L, Valcarcel J, Vázquez JA, Bravo I, Longo A, Salloum-Abou-Jaoude G, Solano E, Gracia-Fernández C, Piñeiro MM, Hermida-Merino D. Gels. 2022 Apr 12;8(4):237. PMID: 35448138; PMCID: PMC9026235. doi: 10.3390/gels8040237.
Multifunctional PLA/Gelatin Bionanocomposites for Tailored Drug Delivery Systems
Moya-Lopez C, Juan A, Donizeti M, Valcarcel J, Vazquez JA, Solano E, Chapron D, Bourson P, Bravo I, Alonso-Moreno C, Clemente-Casares P, Gracia-Fernández C, Longo A, Salloum-Abou-Jaoude G, Ocaña A, Piñeiro MM, Hermida-Merino C, Hermida-Merino D. Pharmaceutics. 2022...
Enhanced Antitumoral Activity of Encapsulated BET Inhibitors When Combined with PARP Inhibitors for the Treatment of Triple-Negative Breast and Ovarian Cancers
Juan A, Noblejas-López MDM, Bravo I, Arenas-Moreira M, Blasco-Navarro C, Clemente-Casares P, Lara-Sánchez A, Pandiella A, Alonso-Moreno C, Ocaña A Cancers (Basel). 2022 Sep 15;14(18):4474. PMID: 36139634; PMCID: PMC9496913. doi: 10.3390/cancers14184474.
BOOKS / CHAPTERS
Homogeneous Catalysis
Sustainable Organic Synthesis: Tools and Strategies ISBN: 978-1-83916-203-9 Editors: Stefano Protti, Alessandro Palmieri Authors: Felipe de la Cruz-Martínez, Marc Martínez de Sarasa Buchaca, Carlos Alonso-Moreno, Agustin Lara-Sánchez, José Antonio Castro-Osma
Catalytic synthesis of bio-sourced organic carbonates and sustainable hybrid materials from CO2.
chapter 6 in Advances in Catalysis, volume 70, 2022 Authors: de la Cruz-Martínez, F.; Castro-Osma, J. A.; Lara-Sánchez, A. Ed. M. Diéguez
Homogeneous aluminum and iron catalysts for the synthesis of organic molecules and biodegradable polymers
X Wu, KJ Lamb, A Lara-Sánchez, C Alonso-Moreno, M North, ... Synthetic Inorganic Chemistry, 3-43
PATENTS
CO2 CAPTURE USING ALKALINE MEDIA FOR THE PREPARATION OF SODIUM CARBONATE
Inventores/autores/obtentores: Juan Antonio Montero, Javier Nieto, Jorge Enrique Zafrilla, Santiago García-Yuste, Jesús Canales-Vázquez, Abdessamad Gueddari, Carlos Alonso-Moreno. Entidad titular de derechos: UCLM/ALTOSA Nº de solicitud: EP20382970.0, 10/11/2020 País...
Selective sulfate anion detection using guanylated fluorophores
Inventores/autores/obtentores: Iván Bravo Pérez, Carlos Alonso Moreno, Fernando Carrillo Hermosilla, Pedro José Pacheco Liñán Entidad titular de derechos: UCLM Nº de solicitud: EP21382203.4 País de inscripción: Europa
REVIEWS
Options to Improve the Action of PROTACs in Cancer: Development of Controlled Delivery Nanoparticles
Juan A, Del Mar Noblejas-López M, Arenas-Moreira M, Alonso-Moreno C, Ocaña A. Front Cell Dev Biol. 2022 Feb 3;9:805336. PMID: 35186955; PMCID: PMC8851355 doi: 10.3389/fcell.2021.805336.
Antibody Conjugation of Nanoparticles as Therapeutics for Breast Cancer Treatment
Juan A, Cimas FJ, Bravo I, Pandiella A, Ocaña A, Alonso-Moreno C. Therapeutics for Breast Cancer Treatment. Int J Mol Sci. 2020 Aug 21;21(17):6018. PMID: 32825618; PMCID: PMC7504566. doi: 10.3390/ijms21176018.
An Overview of Antibody Conjugated Polymeric Nanoparticles for Breast Cancer Therapy
Juan A, Cimas FJ, Bravo I, Pandiella A, Ocaña A, Alonso-Moreno C. Pharmaceutics. 2020 Aug 25;12(9):802. PMID: 32854255; PMCID: PMC7558516. doi: 10.3390/pharmaceutics12090802.